Comparison of the capacities of two prothrombin complex concentrates to restore thrombin generation in plasma from orally anticoagulated patients: An in vitro study

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 6, 2008, Pages 962-968

  Dargaud, Y ^a,b   Desmurs clavel, H ^a   Marin, S ^a   Bordet, J C ^a,b   Poplavsky, J L ^c   Negrier, C ^a,b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c EDDC   (Belgium)

Author keywords

Calibrated automated thrombography; Protein C; Prothrombin complex concentrates; Thrombin generation; Zymogen overload

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; FLUINDIONE; OCTAPLEX; PHOSPHOLIPID; PROTEIN C; PROTEIN S; PROTHROMBIN; PROTHROMBIN COMPLEX; THROMBIN; THROMBOPLASTIN;

ADULT; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; FRANCE; HEMOSTASIS; HUMAN; IN VITRO STUDY; INTERNATIONAL NORMALIZED RATIO; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THROMBIN TIME; THROMBOCYTE FREE PLASMA;

EID: 43749091733     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2008.02964.x     Document Type: Article

References (26)

1. 1 Hellstern P, Halbmayer WM, Kohler M, Seitz R, Muller‐Berghaus G. Prothrombin complex concentrates: indications, contraindications and risks: a task force summary. Thromb Res 1999 ; 4 (Suppl. 1): S3–6.
2. 2 Steiner T, Rosand J, Diringer M. Intracerebral hemorrhage associated with oral anticoagulant therapy. Current practices and unresolved questions. Stroke 2006 ; 37: 256–62.
3. 3 Pindur G, Morsdorf S. The use of prothrombin complex concentrates in the treatment of hemorrhages induced by oral anticoagulation. Thromb Res 1999 ; 4 (Suppl. 1): S57–61.
4. 4 Kasper CK. Thromboembolic complications. Thromb Diath Haemorrh 1975 ; 33: 640–4.
5. 5 Marassi A, Manzullo V, Di Carlo V, Mannucci PM. Thromboembolism following prothrombin complex concentrates and major surgery in severe liver disease. Thromb Haemost 1978 ; 39: 787–8.
6. 6 Roddie PH, Stirling C, Mayne EE, Ludlam CA. Thrombosis and dissemianted intravascular coagulation following treatment with the prothrombin complex concentrate, DEFIX. Thromb Haemost 1999 ; 81: 667.
7. 7 Madden TD, Bally MB, Hope MJ, Cullis PR, Schieren HP, Janoff AS. Protection of large unilamellar vesicles by trehalose during dehydration: retention of vesicle contents. Biochim Biophys Acta 1985 ; 817: 67–74.
8. 8 Hedegaard E, Jensen B. Nano‐scale densitometric quantitation of phospholipids. J Chromatogr 1981 ; 225: 450–4.
9. 9 Hemker HC, Giesen P, Al Dieri R, Regnault V, De Smedt E, Wagenvoord R, Lecompte T, Béguin S. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb. 2003 ; 33: 4–15.
10. 10 Hemker HC, Giesen P, AlDieri R, Regnault V, De Smed E, Wagenvoord R, Lecompte T, Béguin S. The calibrated automated thrombogram (CAT): a universal routine test for hyper‐ and hypocoagulability. Pathophysiol Haemost Thromb 2002 ; 32: 249–53.
11. 11 White GC II, Roberts HR, Kingdon HS, Lundblad RL. Prothrombin complex concentrates: potentially thrombogenic materials and clues to the mechanism of thrombosis in vivo. Blood 1977 ; 49: 159–70.
12. 12 Köhler M, Hellstern P, Lechler E, Uberfuhr P, Müller‐Berghaus G. Thromboembolic complications associated with the use of prothrombin complex and factor IX concentrates. Thromb Haemost 1998 ; 80: 399–402.
13. 13 Makris M, Watson HG. The management of coumarin‐induced over‐anticoagulation. Br J Haematol 2001 ; 114: 271–80.
14. 14 Dusel CH, Grundmann C, Eich S, Seitz R, König H. Identification of prothrombin as a major thrombogenic agent in prothrombin complex concentrates. Blood Coagul Fibrinolysis 2004 ; 15: 405–11.
15. 15 Butenas S, Van’t Veer C, Mann KG. Normal thrombin generation. Blood 1999 ; 94: 2169–78.
16. 16 De Visser MC, Poort SR, Vos HL, Rosendaal FR, Bertina RM. Factor X levels, polymorphisms in the promoter region of factor X, and the risk of venous thrombosis. Thromb Haemost 2001 ; 85: 1011–7.
17. 17 Koster T, Rosendaal FR, Briët E, Van Der Meer FJ, Colly LP, Trienekens PH, Poort SR, Reitsma PH, Vandenbroucke JP. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood 1995 ; 85: 2756–61.
18. 18 Dargaud Y, Trzeciak MC, Bordet JC, Ninet J, Negrier C. Use of calibrated automated thrombinography +/‐ thrombomodulin to recognise the prothrombotic phenotype. Thromb Haemost 2006 ; 96: 562–7.
19. 19 Hron G, Kollars M, Binder BR, Eichinger S, Kyrle PA. Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA 2006 ; 296: 397–402.
20. 20 Staudinger T, Frass M, Rintelen C, Quehenberger P, Wagner O, Stoiser B, Locker GJ, Laczika K, Knapp S, Watzke H. Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients. Intensive Care Med 1999 ; 25: 1105–10.
21. 21 Kessler CM. Urgent reversal of warfarin with prothrombin complex concentrate: where are the evidence‐based data? J Thromb Haemost 2006 ; 4: 963–6.
22. 22 Makris M, Greaves M, Phillips WS, Kitchen S, Rosendaal FR, Preston FE. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost 1997 ; 77: 477–80.
23. 23 Jackson CM, Esnouf MP, Lindahl TL. A critical evaluation of the prothrombin time for monitoring oral anticoagulant therapy. Pathophysiol Haemost Thromb 2003 ; 33: 43–51.
24. 24 Varadi K, Negrier C, Berntorp E, Astermark J, Bordet JC, Morfini M, Linari S, Schwarz HP, Turecek PL. Monitoring the bioavailability of Feiba with a thrombin generation assay. J Thromb Haemost 2003 ; 1: 2374–80.
25. 25 Dargaud Y, Lienhart A, Meunier S, Hequet O, Chavanne H, Chamouard V, Marin S, Negrier C. Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decision. Haemophilia 2005 ; 11: 552–8.
26. 26 Hemker HC. The initiation phase–a review of old (clotting‐) times. Thromb Haemost 2007 ; 98: 20–3.